Tumor immunity and prolonged survival following combined adenovirus-HSP72 and CEA-plasmid vaccination

Vaccine

Volumn 23, Issue 27, 2005, Pages 3565-3571

  Myers, Adrienne L ^a   Krewet, James A ^a   Shah, Maulik R ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY CANCER CENTER   (United States)

Author keywords

Adenovirus; Adjuvant; Carcinoembryonic antigen; DNA vaccination; Heat shock protein 72

Indexed keywords

CANCER VACCINE; CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; DNA VACCINE; HEAT SHOCK PROTEIN 72; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; PLASMID DNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; TUMOR; TUMOR IMMUNITY; VIRUS RECOMBINANT;

EID: 18044392053     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.148     Document Type: Article

References (25)

1. V. Randrianarison-Jewtoukoff, and M. Perricaudet Recombinant adenoviruses as vaccines Biologicals 23 2 1995 145 157
2. M.E. Truckenmiller, and C.C. Norbury Viral vectors for inducing CD8(+) T-cell responses Expert Opin Biol Ther 4 6 2004 861 868
3. K. Song, Y. Chang, and G.J. Prud'homme IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice Gene Ther 7 18 2000 1527 1535
4. K. Song, Y. Chang, and G.J. Prud'homme Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer Gene Ther 7 6 2000 481 492
5. M. Haslbeck sHsps and their role in the chaperone network Cell Mol Life Sci 59 10 2002 1649 1657
6. P.K. Srivastava, and M. Heike Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? Semin Immunol 3 1 1991 57 64
7. C. Castelli, L. Rivoltini, F. Rini, F. Belli, A. Testori, and M. Maio Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer Cancer Immunol Immunother 53 3 2004 227 233
8. P.K. Srivastava, and R.J. Amato Heat shock proteins: the Swiss Army Knife vaccines against cancers and infectious agents Vaccine 19 17-19 2001 2590 2597
9. S.P. Yedavelli, L. Guo, M.E. Daou, P.K. Srivastava, A. Mittelman, and R.K. Tiwari Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model Int J Mol Med 4 3 1999 243 248
10. A. Melcher, S. Todryk, N. Hardwick, M. Ford, M. Jacobson, and R.G. Vile Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression Nat Med 4 5 1998 581 587
11. S. Somersan, M. Larsson, J.F. Fonteneau, S. Basu, P. Srivastava, and N. Bhardwaj Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells J Immunol 167 9 2001 4844 4852
12. S. Okubo, O. Wildner, M.R. Shah, J.C. Chelliah, M.L. Hess, and R.C. Kukreja Gene transfer of heat-shock protein 70 reduces infarct size in vivo after ischemia/reperfusion in the rabbit heart Circulation 103 6 2001 877 881
13. P. Ng, and F.L. Graham Construction of first-generation adenoviral vectors Methods Mol Med 69 2002 389 414
14. N. Mittereder, K.L. March, and B.C. Trapnell Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy J Virol 70 11 1996 7498 7509
15. R.M. Conry, A.F. LoBuglio, F. Loechel, S.E. Moore, L.A. Sumerel, and D.L. Barlow A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity Gene Ther 2 1 1995 59 65
16. M.J. Estcourt, A.J. Ramsay, A. Brooks, S.A. Thomson, C.J. Medveckzy, and I.A. Ramshaw Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population Int Immunol 14 1 2002 31 37
17. G. Ada, and I. Ramshaw DNA vaccination Expert Opin Emerg Drugs 8 1 2003 27 35
18. S. Sasaki, F. Takeshita, K.Q. Xin, N. Ishii, and K. Okuda Adjuvant formulations and delivery systems for DNA vaccines Methods 31 3 2003 243 254
19. S. Lee, M. Gierynska, S.K. Eo, N. Kuklin, and B.T. Rouse Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus Microbes Infect 5 7 2003 571 578
20. W. Chen, Y. Lin, C. Liao, and S. Hsieh Modulatory effects of the human heat shock protein 70 on DNA vaccination J Biomed Sci 7 5 2000 412 419
21. U.K. Rapp, and S.H. Kaufmann DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen Int Immunol 16 4 2004 597 605
22. H. Hauser, and S.Y. Chen Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting Methods 31 3 2003 225 231
23. P.W. Zoltick, N. Chirmule, M.A. Schnell, G.P. Gao, J.V. Hughes, and J.M. Wilson Biology of E1-deleted adenovirus vectors in nonhuman primate muscle J Virol 75 11 2001 5222 5229
24. V. Molinier-Frenkel, R. Lengagne, F. Gaden, S.S. Hong, J. Choppin, and H. Gahery-Segard Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response J Virol 76 1 2002 127 135
25. D.A. Muruve, M.J. Barnes, I.E. Stillman, and T.A. Libermann Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo Hum Gene Ther 10 6 1999 965 976